Trial: 202108161

SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Phase

III (Cancer Control)

Principal Investigator

Weiss, Mia

Disease Site

Soft Tissue

Learn more about this study at: clinicaltrials.gov